The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics
Abstract
Cerebrospinal fluid (CSF) routine analysis for diagnosis of neurological diseases is based on the concepts for discrimination of blood-derived and brain-derived immunoglobulin fractions in CSF. The actual molecular flux/CSF flow theory of the blood/CSF barrier function, which founded the hyperbolic discrimination lines in quotient diagrams, is derived from the laws of molecular diffusion combined with CSF flow rate. It emerged from this theory that the decrease of CSF flow rate is sufficient to explain quantitatively the increase of CSF protein concentrations as observed in many neurological diseases. With this concept of CSF flow rate as the modulator of the normal and pathological blood-CSF barrier function, we got for the first time a theoretical frame work to explain also quantitatively the dynamics of brain-derived proteins and their source related (neurons and glial cells or leptomeningal cells) differences. The review of the anatomical, physiological and biophysical knowledge points to the new interpretations: The changing albumin quotient is an indicator of changing CSF flow rate and not for a morphological "leakage" of the blood-brain barrier. As an application of these concepts the dynamics of brain-derived molecules in blood are discussed with two examples: beta trace protein, flowing with CSF into venous blood, and neuron-specific enolase, passing from tissue into blood the opposite direction of serum proteins, again a gradient-dependent protein diffusion across the intact blood vessel wall.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemical basis of morphogenesis
Turing, A. M. (1952) · Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences · doi:10.1098/rstb.1952.0012 · Cited by 11,733
Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier
Huber, J. D., Egleton, R. D., & Davis, T. P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02004-x · Cited by 786
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs
Reiber, H., & Peter, J. B. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00501-3 · Cited by 731
Self-citationImproved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., Deyn, P. P. D., Bancher, C., Cras, P., Wiltfang, J., Mehta, P. D., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1555 · Cited by 724 · cited 1×
“…the dynamics of blood-derived proteins in CSF. Brain-derived proteins in CSF and blood, which are of increasing diagnostic relevance [13] [14] [15] [16] [17] [18] [19], present an important extension of the basic CSF analysis program, in particular the observation that the dynamics of…”
BackgroundReiber, H. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90298-4 · Cited by 529
Self-citationDynamics of brain-derived proteins in cerebrospinal fluid
Reiber, H. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00573-3 · Cited by 516
Self-citationReiber, H., & Felgenhauer, K. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90250-6 · Cited by 461
Self-citationProtein size and cerebrospinal fluid composition
Felgenhauer, K. (1974) · Klinische Wochenschrift · doi:10.1007/bf01466734 · Cited by 396
Link, H., & Tibbling, G. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517709091498 · Cited by 372
Cerebrospinal fluid production is reduced in healthy aging
May, C., Kaye, J. A., Atack, J. R., Schapiro, M. B., Friedland, R. P., & Rapoport, S. I. (1990) · Neurology · doi:10.1212/wnl.40.3_part_1.500 · Cited by 315
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease
Otto, M., Wiltfang, J., Cepek, L., Neumann, M., Mollenhauer, B., Steinacker, P., Ciesielczyk, B., Schulz–Schaeffer, W., Kretzschmar, H. A., & Poser, S. (2002) · Neurology · doi:10.1212/wnl.58.2.192 · Cited by 289
Physiology of the Ocular and Cerebrospinal Fluids
(1957) · Journal of the American Medical Association · doi:10.1001/jama.1957.02970440089030 · Cited by 258
Traumatic Brain Damage: Serum S-100 Protein Measurements Related to Neuroradiological Findings
Romner, B., Ingebrigtsen, T., Kongstad, P., & Børgesen, S. E. (2000) · Journal of Neurotrauma · doi:10.1089/089771500415391 · Cited by 220
Zerr, I., Bodemer, M., Räcker, S., Grosche, S., Poser, S., Weber, T., & Kretzschmar, H. A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90118-3 · Cited by 165
A proposed model of cerebrospinal fluid circulation: observations with radionuclide cisternography.
Greitz, D., & Hannerz, J. (1996) · PubMed Central · Cited by 135
Reiber, H., Ruff, M., & Uhr, M. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90162-w · Cited by 112
Self-citationThe CSF proteins: A biochemical approach
Thompson, E. J. (1988) · Medical Entomology and Zoology · Cited by 110
Reporting Cerebrospinal Fluid Data: Knowledge Base and Interpretation Software
Reiber, H., Otto, M., Trendelenburg, C., & Wormek, A. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.051 · Cited by 102
Self-citationHuman gamma-trace. Structure, function and clinical use of concentration measurements.
GRUBB, A. O., & Löfberg, H. (1985) · PubMed · Cited by 60
Clinical relevance of increased neuron-specific enolase concentration in cerebrospinal fluid
Jacobi, C., & Reiber, H. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90306-3 · Cited by 58
Self-citationStrik, C., Klose, U., Erb, M., Strik, H. M., & Grodd, W. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10084 · Cited by 56
Intrathecal immunoglobulin synthesis
Souverijn, J. H. M., Serrée, H. M. P., Peet, R., Smit, W. G., & Bruyn, G. W. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90087-n · Cited by 32
Passage of Proteins from Blood to Cerebrospinal Fluid
Rapoport, S. I. (1983) · Springer eBooks · doi:10.1007/978-1-4615-9269-3_16 · Cited by 25
Cited by
Anatomy and physiology of cerebrospinal fluid
Sakka, L., Coll, G., & Chazal, J. (2011) · European Annals of Otorhinolaryngology, Head and Neck Diseases · doi:10.1016/j.anorl.2011.03.002 · Cited by 815
CSF, blood-brain barrier, and brain drug delivery
Pardridge, W. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1171315 · Cited by 508
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Pardridge, W. M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00373 · Cited by 405
“Owing to the leakiness of the choroid plexus, all proteins in plasma distribute into CSF inversely related to the molecular weight of the protein (Reiber, 2003).”
BackgroundMollenhauer, B., Cullen, V., Kahn, I., Krastins, B., Outeiro, T. F., Pepivani, I., Ng, J., Schulz-Schaeffer, W., Kretzschmar, H. A., McLean, P. J., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.004 · Cited by 382
Kuhle, J., Barro, C., Disanto, G., Mathias, A., Soneson, C., Bonnier, G., Yaldizli, Ö., Regeniter, A., Derfuss, T., Canales, M., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515623365 · Cited by 257
Metadata
- Authors
- Reiber, H.
- Venue
- Restorative Neurology and Neuroscience
- Publisher
- SAGE Publications
- Published
- 2003-01-01
- Volume
- 21
- Issue
- 3-4
- Pages
- 79-96
- ISSN
- 0922-6028 (ISSN-L)
- 1878-3627
- OpenAlex
- W2113074743
- Cited by
- 348
- References
- 23
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.